RPR To Pursue Synercid Pneumonia Indication With Early-2000 Submission

Rhone-Poulenc Rorer will submit results of a second hospital-acquired pneumonia study to FDA in early-2000 to broaden the indication for its injectable streptogramin antibiotic Synercid.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet